XENE SG&A Expense Growth
Xenon Pharmaceuticals Inc · SG&A Expense Growth
XENE SG&A Expense Growth
Latest reported15.57%period ending
XENE FY SG&A Growth (YoY) (0.00% → 15.57%)
Latest values, visible window
High-resolution chart · PNG
XENE sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 15.5695% | |
| 48.0469% | |
| 41.8531% | |
| 49.3604% | |
| 69.708% | |
| 19.8186% | |
| 28.8833% | |
| 14.6178% | |
| 7.6708% | |
| -30.5947% | |
| 78.0568% | |
| 2.9021% | |
| -23.7653% | |
| 4.101% | |
| 0% |